MADELYN DOOLEY: Open Payments
NPI 1851783864 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$900 in 55 payments from 18 companies in 2025. Trend: 2023 $164 · 2024 $2,509 · 2025 $900
Food & beverage: $900
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 16 | $193 |
| Amgen Inc. | 10 | $149 |
| Insulet Corporation | 5 | $118 |
| Tandem Diabetes Care, Inc. | 4 | $56 |
| Abbott Laboratories | 2 | $50 |
| Neurocrine BioSciences, Inc. | 2 | $44 |
| Xeris Pharmaceuticals, Inc. | 2 | $41 |
| SANOFI-AVENTIS U.S. LLC | 2 | $39 |
| Corcept Therapeutics | 2 | $32 |
| RECORDATI_RARE_DISEASES_INC. | 2 | $31 |
Products named: Dexcom G6 Transmitter, Omnipod, TEPEZZA, t:slim X2 Insulin Pump with Control-IQ, TAVNEOS, FREESTYLE LIBRE 3, CRENESSITY, RECORLEV.
Industry payments across LA — which companies pay providers there.
